341 related articles for article (PubMed ID: 18173535)
1. Prospective study of urticaria after diphencyprone therapy in patients with viral warts.
Choi JE; Seo SH; Kim IH; Son SW
Int J Dermatol; 2007 Dec; 46(12):1313-4. PubMed ID: 18173535
[No Abstract] [Full Text] [Related]
2. Urticaria as a side-effect of diphencyprone therapy for resistant viral warts.
Short KA; Higgins EM
Br J Dermatol; 2005 Mar; 152(3):583-5. PubMed ID: 15787842
[No Abstract] [Full Text] [Related]
3. Generalized urticaria with use of diphencyprone in the treatment of warts.
Culp BL; Wells MJ
J Drugs Dermatol; 2007 May; 6(5):529-30. PubMed ID: 17679188
[TBL] [Abstract][Full Text] [Related]
4. Urticarial vasculitis due do infliximab.
Goulão J; Cunha H; Anes I; Bártolo E; Furtado C; Serrano P; Brandão FM
J Eur Acad Dermatol Venereol; 2008 Jul; 22(7):882-3. PubMed ID: 18462298
[No Abstract] [Full Text] [Related]
5. A case of pityriasis lichenoides et varioliformis acuta after topical application of diphenylcyclopropenone.
Nam KH; Park SW; Jung ES; Lee SK
Eur J Dermatol; 2020 Jun; 30(3):317-318. PubMed ID: 32540809
[No Abstract] [Full Text] [Related]
6. An interesting response to diphencyprone (DPC) sensitization on facial warts: review of DPC treatment for viral warts.
Pollock B; Highet AS
J Dermatolog Treat; 2002 Jun; 13(2):47-50. PubMed ID: 12060501
[TBL] [Abstract][Full Text] [Related]
7. Comparative study on the sustained efficacy of diphencyprone immunotherapy versus cryotherapy in viral warts.
Choi MH; Seo SH; Kim IH; Son SW
Pediatr Dermatol; 2008; 25(3):398-9. PubMed ID: 18577059
[TBL] [Abstract][Full Text] [Related]
8. Treatment of palmoplantar warts with a diphencyprone and salicylic acid ointment.
Armour K; Orchard D
Australas J Dermatol; 2006 Aug; 47(3):182-5. PubMed ID: 16866999
[TBL] [Abstract][Full Text] [Related]
9. Topical immunotherapy: unapproved uses, dosages, or indications.
Higgins E; du Vivier A
Clin Dermatol; 2002; 20(5):515-21. PubMed ID: 12435522
[No Abstract] [Full Text] [Related]
10. Diphencyprone immunotherapy for viral warts in immunosuppressed patients.
Audrain H; Siddiqui H; Buckley DA
Br J Dermatol; 2013 May; 168(5):1138-9. PubMed ID: 23210741
[No Abstract] [Full Text] [Related]
11. Topical immunotherapy with diphenylcyclopropenone in the treatment of chronic extensive alopecia areata.
Sotiriadis D; Patsatsi A; Lazaridou E; Kastanis A; Vakirlis E; Chrysomallis F
Clin Exp Dermatol; 2007 Jan; 32(1):48-51. PubMed ID: 17004987
[TBL] [Abstract][Full Text] [Related]
12. Topical immunotherapy in dermatology.
Buckley DA; du Vivier AW
Int J Clin Pract; 1999 Mar; 53(2):130-7. PubMed ID: 10344049
[TBL] [Abstract][Full Text] [Related]
13. Urticaria after topical immunotherapy with diphenylcyclopropenone.
Francomano M; Seidenari S
Contact Dermatitis; 2002 Nov; 47(5):310-1. PubMed ID: 12534538
[No Abstract] [Full Text] [Related]
14. What factors affect the duration of treatment with diphenylcyclopropenone immunotherapy for common warts?
Seo HM; Park HK; Kim TL; Kim JS
Dermatol Ther; 2018 Nov; 31(6):e12740. PubMed ID: 30203625
[No Abstract] [Full Text] [Related]
15. Treatment of disseminated facial warts through contact immunotherapy with diphenylcyclopropenone (DPCP).
Aghaei S
Dermatol Online J; 2006 Feb; 12(2):10. PubMed ID: 16638403
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy of warts with masoprocol cream.
Epstein E
Cutis; 1997 May; 59(5):287-9. PubMed ID: 9169274
[No Abstract] [Full Text] [Related]
17. [Regression of plantar warts following treatment with diphencyprone].
Wiesner-Menzel L; Happle R
Z Hautkr; 1984 Aug; 59(16):1080-3. PubMed ID: 6485456
[TBL] [Abstract][Full Text] [Related]
18. Topical zinc oxide vs. salicylic acid-lactic acid combination in the treatment of warts.
Khattar JA; Musharrafieh UM; Tamim H; Hamadeh GN
Int J Dermatol; 2007 Apr; 46(4):427-30. PubMed ID: 17442091
[TBL] [Abstract][Full Text] [Related]
19. Alopecia areata: topical immunotherapy treatment with diphencyprone.
Avgerinou G; Gregoriou S; Rigopoulos D; Stratigos A; Kalogeromitros D; Katsambas A
J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):320-3. PubMed ID: 18005118
[TBL] [Abstract][Full Text] [Related]
20. Pigmented contact dermatitis due to therapeutic sensitizer as complication of contact immunotherapy in alopecia areata.
Inui S; Nakajima T; Toda N; Itami S
J Dermatol; 2010 Oct; 37(10):888-93. PubMed ID: 20860739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
